Lallemand Health Solutions’ L. rhamnosus HA-114 may curb overeating, reduce insulin resistance

Supplier Profiles On Nutrition Insight
Lallemand Health Solutions

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

US-based Eli Lilly and Company has received US Food and Drug Administration (FDA) approval for Lilly’s Mounjaro, a tirzepatide injection treatment for Type 2... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Lallemand is partnering with the French Gut Project to innovate in health and science by driving microbiota science forward. The project aims to collect and analyze... Read More

FormattedPicture

FOOD INGREDIENTS NEWS

Research published in Cell Metabolism funded by the Medical Research Council found that the same amount of calories were burned independent of at what time of day they... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Lallemand Health Solutions’ two bacterial strains, L. helveticus Rosell-52 and B. bifidum Rosell-71, may support the development of beneficial gut microflora in... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

US legislators in California’s senate have passed bill AB 1341, prohibiting the sale of over-the-counter diet pills and weight-loss supplements to minors. With an... Read More

trans